New Lundbeck exec to get firm's next research leg started

Lundbeck's executive group used a strict checklist to find its new head of R&D, and Tarek Samad, who will be taking on the job on May 1, scored top marks on one parameter in particular.

Photo: PR / Lundbeck

Lundbeck's decision to find a new head of research and development is part of a major reorganization of the company's R&D unit, which has been going on for a while, the Danish pharmaceutical firm's Executive Vice President & Head of Research & Development Johan Luthman tells MedWatch.

Luthman gave up several names for the recruitment group himself, since he has worked in neuroscience for many years. However, he did not actually know the candidate whom Lundbeck ended up hiring, Tarek Samad, beforehand.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs